Bigul

HealthCare Global Enterprises Ltd - 539787 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mitsubishi UFJ Financial Group
06-08-2019
Bigul

HealthCare Global Enterprises Ltd - 539787 - Correction In The Consolidated Financial Results For The Quarter And Year Ended 31 March 2019.

Correction in the consolidated financial results for the quarter and year ended 31 March 2019.
02-08-2019
Bigul

HealthCare Global Enterprises Ltd - 539787 - Board Meeting Intimation for To Approve The Unaudited Financial Statements Of The Company For The Quarter Ended June 30, 2019; And To Authorize Chairman & CEO To Sign The Same On Behalf Of The Board. To Issue And Allot Equity Shares Of The Company To Eligible Employees Under Employee Stock Option Scheme Of The Company, Upon The Exercise Of Vested Stock Options.

Healthcare Global Enterprises Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2019 ,inter alia, to consider and approve unaudited financial statements of the Company for the quarter ended June 30, 2019 and issue and allot Equity Shares of the Company to eligible employees under ESOP scheme, up on exercise of vested stock options.
24-07-2019
Bigul

HealthCare Global Enterprises Ltd - 539787 - Statement Of Investor Complaints For The Quarter Ended June 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sunu ManuelDesignation :- Company Secretary and Compliance Officer
19-07-2019
Bigul

HealthCare Global Enterprises Ltd - 539787 - Shareholding for the Period Ended June 30, 2019

HealthCare Global Enterprises Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here
17-07-2019
Bigul

HCG joins hands with Stanford varsity to offer outcome-based cancer treatment

Stanford University, California, will collaborate with Healthcare Global Enterprises (HCG), the cancer care specialist, to implement evidence-based s
03-07-2019
Bigul

HealthCare Global Enterprises Ltd - 539787 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. B.S Ajaikumar & Dr. Ganesh Nayak
01-07-2019
Bigul

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Allotment

Intimation with respect to allotment of Equity Shares on Preferential basis.
25-06-2019
Next Page
Close

Let's Open Free Demat Account